Stocks Overview

LAST PRICE
2.8000
TODAY'S CHANGE (%)
Trending Up0.0800 (2.9412%)

Bid / Lots
2.7200/ 3
Ask / Lots
3.0000/ 5
Open / Previous Close
2.7500 / 2.7200
Day Range
Low 2.6100
High 2.9000
52 Week Range
Low 2.6100
High 27.3500
Volume
475,322
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.72
Time	Volume	RAPT
09:32 ET	4799	2.72
09:34 ET	200	2.71
09:36 ET	725	2.71
09:38 ET	5100	2.65
09:39 ET	702	2.66
09:41 ET	200	2.65
09:43 ET	1500	2.675
09:45 ET	1150	2.69
09:48 ET	100	2.68
09:50 ET	1966	2.67
09:52 ET	500	2.65
09:54 ET	1526	2.65
09:56 ET	1100	2.64
09:57 ET	300	2.64
09:59 ET	700	2.63
10:01 ET	695	2.64
10:03 ET	300	2.64
10:06 ET	1045	2.66
10:08 ET	1200	2.64
10:10 ET	678	2.64
10:14 ET	200	2.6453
10:15 ET	200	2.64
10:19 ET	1158	2.6485
10:24 ET	1239	2.62
10:26 ET	1800	2.62
10:28 ET	300	2.6399
10:30 ET	3500	2.62
10:32 ET	1424	2.626
10:33 ET	200	2.6201
10:35 ET	670	2.62
10:37 ET	300	2.62
10:39 ET	300	2.62
10:42 ET	3845	2.65
10:44 ET	6700	2.68
10:46 ET	1984	2.69
10:48 ET	100	2.7
10:50 ET	1490	2.7
10:51 ET	1670	2.71
10:53 ET	1480	2.7399
10:57 ET	4191	2.76
11:00 ET	3250	2.76
11:02 ET	300	2.77
11:04 ET	1300	2.76
11:06 ET	1100	2.77
11:08 ET	3599	2.78
11:09 ET	400	2.78
11:11 ET	7831	2.81
11:13 ET	1500	2.8111
11:15 ET	5102	2.8207
11:18 ET	13318	2.845
11:24 ET	1696	2.815
11:26 ET	600	2.815
11:27 ET	100	2.8
11:29 ET	400	2.815
11:31 ET	800	2.82
11:33 ET	950	2.81
11:38 ET	200	2.8
11:40 ET	600	2.81
11:42 ET	3186	2.81
11:44 ET	600	2.825
11:45 ET	400	2.825
11:47 ET	200	2.85
11:49 ET	200	2.85
11:51 ET	923	2.865
11:54 ET	4565	2.9
11:56 ET	3652	2.88
11:58 ET	700	2.86
12:02 ET	2131	2.85
12:05 ET	1886	2.8505
12:07 ET	856	2.85
12:09 ET	1800	2.86
12:12 ET	1456	2.87
12:14 ET	500	2.86
12:16 ET	1000	2.8599
12:18 ET	1812	2.86
12:20 ET	500	2.86
12:23 ET	1007	2.85
12:25 ET	400	2.85
12:27 ET	200	2.85
12:32 ET	2588	2.8305
12:34 ET	1600	2.82
12:36 ET	2110	2.83
12:38 ET	345	2.82
12:39 ET	238	2.82
12:41 ET	3966	2.82
12:43 ET	532	2.81
12:45 ET	407	2.8
12:48 ET	300	2.8
12:50 ET	575	2.81
12:52 ET	300	2.8
12:54 ET	2032	2.81
12:56 ET	1056	2.801
12:57 ET	500	2.8
12:59 ET	392	2.82
01:01 ET	200	2.82
01:08 ET	100	2.8
01:10 ET	3343	2.78
01:12 ET	3975	2.78
01:14 ET	200	2.78
01:15 ET	625	2.78
01:17 ET	1001	2.785
01:19 ET	100	2.785
01:21 ET	100	2.78
01:24 ET	125	2.78
01:28 ET	200	2.785
01:30 ET	200	2.78
01:35 ET	100	2.77
01:48 ET	5070	2.74
01:51 ET	100	2.74
01:55 ET	100	2.74
02:02 ET	900	2.73
02:06 ET	100	2.73
02:09 ET	100	2.73
02:13 ET	100	2.747
02:18 ET	2300	2.725
02:20 ET	100	2.725
02:22 ET	800	2.72
02:24 ET	100	2.71
02:29 ET	100	2.71
02:31 ET	707	2.71
02:33 ET	1824	2.7
02:36 ET	1730	2.7
02:40 ET	300	2.705
02:42 ET	3694	2.72
02:44 ET	360	2.72
02:47 ET	500	2.7199
02:49 ET	100	2.71
02:54 ET	11201	2.77
02:56 ET	13055	2.8
02:58 ET	4527	2.78
03:00 ET	312	2.78
03:02 ET	6658	2.7601
03:03 ET	100	2.76
03:07 ET	200	2.76
03:09 ET	1000	2.76
03:12 ET	600	2.76
03:14 ET	421	2.76
03:16 ET	927	2.78
03:18 ET	600	2.775
03:20 ET	200	2.77
03:21 ET	818	2.77
03:25 ET	684	2.76
03:27 ET	300	2.76
03:30 ET	1200	2.76
03:32 ET	264	2.76
03:34 ET	700	2.76
03:36 ET	3180	2.73
03:38 ET	570	2.73
03:39 ET	6579	2.73
03:41 ET	4458	2.745
03:43 ET	700	2.745
03:45 ET	2708	2.745
03:48 ET	2103	2.73
03:50 ET	4477	2.74
03:52 ET	8614	2.755
03:54 ET	2579	2.75
03:56 ET	9059	2.76
03:57 ET	21545	2.785
03:59 ET	35820	2.8

Data delayed at least 15 minutes.

No documents available

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRAPT RAPT Therapeutics Inc	97.4M	-0.9x	---
United StatesELDN Eledon Pharmaceuticals Inc	95.9M	-1.8x	---
United StatesXFOR X4 Pharmaceuticals Inc	92.2M	-0.8x	---
United StatesBOLD Boundless Bio Inc	92.4M	0.0x	---
United StatesRLMD Relmada Therapeutics Inc	91.1M	-1.0x	---
United StatesATHA Athira Pharma Inc	97.7M	-0.8x	---
As of 2024-07-07

RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its drug discovery and development engine, it develops selective small molecules designed to modulate the critical immune responses underlying these diseases. Its lead inflammation drug candidate, zelnecirnon (RPT193), and its lead oncology drug candidate, tivumecirnon (FLX475), each target C-C motif chemokine receptor 4 (CCR4), a drug target that potentially has broad applicability in inflammatory diseases and oncology. Its inflammation drug candidate, zelnecirnon, is designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its oncology drug candidate, tivumecirnon, is designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors.

Contact Information

Headquarters: 561 Eccles AveSOUTH SAN FRANCISCO, CA, United States 94080-1906
Phone: 650-489-9000
Fax: 302-531-3150

Executives

Independent Chairman of the Board: William Rieflin
President, Chief Executive Officer, Director: Brian Wong
Chief Financial Officer: Rodney Young
Chief Scientific Officer: Dirk Brockstedt
Chief Medical Officer: William Ho

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$97.4M
Revenue (TTM)	$0.00
Shares Outstanding	34.8M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.22
EPS	$-3.07
Book Value	$4.27
P/E Ratio	-0.9x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

RAPT Therapeutics Inc
NASDAQ:RAPTUnited States

Search Criteria

Charts

Recent News

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar